Tyrosine kinase inhibitor levels matter in treating chronic GVHD

Lotte van der Wagen, Julie Janssen, Reinier Raijmakers, Eefke Petersen, Moniek de Witte, Niels de Jong, Mar Bellido, Ellen Meijer, Brigitte Bär, Jaap Jan Boelens, Alwin Huitema, J. rgen Kuball

Research output: Contribution to journalComment/Letter to the editorAcademic

Abstract

We observed a possible concentration effect relationship for nilotinib on resolution of chronic Graft versus Host disease.These data suggest therapeutic drug monitoring might be useful for patients receiving tyrosine kinase inhibitors for chronic GVHD.
Original languageEnglish
Pages (from-to)1141-1144
JournalBone Marrow Transplantation
Volume54
Issue number7
DOIs
Publication statusPublished - 1 Jul 2019

Cite this

van der Wagen, L., Janssen, J., Raijmakers, R., Petersen, E., de Witte, M., de Jong, N., ... Kuball, J. R. (2019). Tyrosine kinase inhibitor levels matter in treating chronic GVHD. Bone Marrow Transplantation, 54(7), 1141-1144. https://doi.org/10.1038/s41409-018-0429-5